Delivery Order N0018924DZ017-N6854625FA023

Award Date 3/7/25
Potential Completion Date 6/1/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fremont, CA 94538, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Microgenics Corporation's Clinical Diagnostics Division. The $8,134.80 firm-fixed price delivery order is for DRI Opiate 500 ML Reagent Test Kits. The award is associated with a larger $750,435 single-award Indefinite Delivery Contract held by Microgenics for DRI Opiate Reagent Test Kits, which supports the Department of Defense Drug Demand Reduction Program by providing a...
This firm-fixed price delivery order was awarded by the Navy Bureau of Medicine and Surgery, a component of the Department of Defense, to Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation. The $20,337 contract is for the supply of DRI Opiate 500 ML Reagents Test Kits, which support substance abuse testing and treatment programs at military medical facilities and VA hospitals. Microgenics has established itself as a key supplier for the Department of...
The U.S. Defense Health Agency awarded a firm-fixed price delivery order contract valued at $16,269.60 to Microgenics Corporation, a subsidiary of Thermo Electron Corporation, for the supply of DRI Opiate 500mL Reagent Test Kits. This contract is associated with a larger indefinite delivery vehicle held by Microgenics, valued at $750,435, which supports the Department of Defense Drug Demand Reduction Program by providing immunoassay reagent test kits and related laboratory supplies to military...
This is a delivery order contract awarded to Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation, by the Air Education and Training Command, which is a component of the U.S. Department of Defense. The contract is for the purchase of DRI Opiate 500ML Reagent Test Kits, with an order value of $8,134.80 and a performance period through December 9, 2024. This order is placed under a larger indefinite delivery contract vehicle with Microgenics, which has a total...
This federal contract award to Microgenics Corporation is a $8,134.80 firm-fixed price delivery order under existing indefinite delivery vehicles (IDVs) with the Department of Defense and Department of Veterans Affairs. The award is for the supply of DRI Opiate 500 ML Reagent Test Kits, which support substance abuse testing and treatment programs at military medical facilities and VA hospitals. Microgenics, a subsidiary of Thermo Electron Corporation, has received multiple prime contract...
This is a delivery order awarded by the Defense Health Agency to Microgenics Corporation, a subsidiary of Thermo Electron Corporation, for the supply of 500ml opiate DRI reagent kits. The $17,625.40 firm-fixed-price contract has a completion date of September 29, 2023 and does not have a set-aside designation. Microgenics is a manufacturer of clinical diagnostic products and toxicology testing solutions, leveraging its parent company's resources to fulfill contracts with various DoD and VA...
This federal contract award was issued by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation. The contract, valued at $11,266.56, is for the delivery of MDMA/MDA reagent kits. This is a delivery order contract with a firm fixed price pricing type. The contract has a period of performance through March 13, 2025. Microgenics Corporation is an established supplier of clinical...
This is a delivery order awarded by the Air Education and Training Command (AETC) of the U.S. Air Force to Microgenics Corporation, a manufacturer of clinical diagnostic products and toxicology testing solutions. The $19,387.94 firm fixed price order is for the supply of DRI opiate reagent test kits to support the Department of Defense Drug Demand Reduction Program. This order falls under a larger indefinite delivery contract held by Microgenics with the AETC, and the company has been awarded...
This is a firm fixed price delivery order awarded by the Defense Health Agency to Microgenics Corporation, a subsidiary of Thermo Electron Corporation Financial Services Division. The contract is for the delivery of DRI OPIATES IA KIT, which are laboratory reagents used to support substance abuse testing and treatment programs at military medical facilities. The award has a potential value of $5,423.20 and a completion date of December 29, 2023. The place of performance is Fort Meade,...
This is a firm-fixed price delivery order contract awarded by the Defense Health Agency to Microgenics Corporation, a subsidiary of Thermo Electron Corporation, for the supply of opiate reagent kits to the Tripler Army Medical Center in Hawaii. The contract has a ceiling value of $6,779.00 and a performance period through April 30, 2024. Microgenics is a manufacturer of clinical diagnostic products and toxicology testing solutions that has received numerous prime contract awards from various...
  • N0018924DZ017
    Indefinite Delivery Contract
  • N0018924DZ017-N6854625FA023
    Delivery Order

This federal contract award is for the supply of DRI Hydrocodone Reagent Kits, 500 milliliters, to the Bureau of Medicine and Surgery, which is a component of the U.S. Department of Defense. The prime contractor is Microgenics Corporation, a for-profit organization and manufacturer of clinical diagnostic products, including toxicology testing solutions for federal agencies.

The contract has a ceiling value of $1,047.85 and is a delivery order under a larger indefinite delivery contract. It does not have a set-aside designation. The contract supports the Department of Defense Drug Demand Reduction Program by providing FDA-approved diagnostic reagents compatible with clinical analyzers used in military and veteran healthcare systems. Microgenics Corporation has been awarded several other significant indefinite delivery contracts by various defense and veterans affairs agencies for a range of toxicology reagent kits and test products.

Generated 6/6/25, 9:48 AM